ACTOS reduces stroke by almost 50 percent

Barcelona, Spain, September 3, 2006 -- Results of new analyses found that ACTOS (pioglitazone HCl), an oral antidiabetic medication, significantly reduced the risk of recurrent stroke in high-risk patients with type 2 diabetes. The findings were presented today in a late-breaker session at the World Congress of Cardiology in Barcelona.

"These results are very encouraging news for people with type 2 diabetes because they demonstrated that ACTOS reduced the incidence of strokes in patients who had already experienced a stroke from 10.2 percent down to 5.6 percent, translating to a risk reduction of almost 50 percent," said Robert Wilcox, M.D., professor in the Department of Cardiovascular Medicine at Queen's Medical Centre, University Hospital, Nottingham, United Kingdom.

These new analyses from the landmark PROactive Study examined the effects of ACTOS on the risk of stroke and other cardiovascular (CV) outcomes in high-risk patients with type 2 diabetes with and without prior stroke. Pre-specified study endpoints included all-stroke and CV disease death, myocardial infarction (MI, excluding silent MI) or stroke.

According to the results, there were statistically significant benefits of ACTOS in patients who had suffered a prior stroke. The incidence of recurrent stroke was reduced by 47 percent (P=0.008) and the combined risk of death, MI or stroke was reduced by 28 percent (P<0.05). There was no effect of ACTOS on subsequent strokes in patients who had never experienced a stroke.

Patients with diabetes are at an increased risk of stroke. In fact, the risk is two to four times higher for people with diabetes than the general population. Results from the PROactive Study demonstrated that an oral glucose-lowering medication could substantially impact the risk of some CV events, including the combined risk of death, MI and stroke in high-risk patients with type 2 diabetes.


Contact: Amy Losak

Page: 1

Related medicine news :

1. ACTOS (pioglitazone HCl) demonstrates significant improvements in cardiovascular outcomes
2. ACTOS (pioglitazone HCl) to be studied in new trial
3. New data shows ACTOS reduced heart attacks by 28 percent in people with type 2 diabetes
4. ACTOS (pioglitazone HCl) significantly improved components of diabetic dyslipidemia
5. Nonhormonal drug reduces hot flashes in men treated for prostate cancer
6. Circumcision reduces HIV infection risk
7. Retinol lotion reduces the fine wrinkles from natural aging of skin
8. Improving communication with families of dying patients reduces stress, anxiety and depression
9. New study: Pycnogenol reduces heart failure
10. Drinking farm milk reduces childhood asthma and allergies but raw consumption remains unsafe
11. Angioplasty reduces long-term cardiac risk among heart patients with silent ischemia

Post Your Comments:

(Date:8/31/2020)... ... ... “PTS” with Mediation & Hypnosis , At this very turbulent time in the world, ... immense stress, and right now are needing serious relief from a constant state of endless ... experiencing a great degree of emotional discomfort, be it fear or worrying about their income ...
(Date:8/31/2020)... HAVEN, Conn. (PRWEB) , ... August 31, 2020 ... ... medical device intended to improve outcomes for patients with advanced heart failure, today ... Research (SBIR) grant in the amount of $555,358 from the National Heart, Lung, ...
(Date:8/28/2020)... ... 28, 2020 , ... WHAT , Hespiro™ is a new ... conditions, including COVID-19, while reducing the need for scarce mechanical ventilators. It not ... and scrubs it free of carbon dioxide in a completely closed “rebreather” system, ...
(Date:8/28/2020)... ... 28, 2020 , ... Integrated Viral Protection (IVP Air) today announced ... deploy its breakthrough Mobile Biodefense Indoor Air Protection System that is the first system ... to fully reopen equipped with the filtration system on September 8th. , The ...
(Date:8/27/2020)... GREENVALE, N.Y. (PRWEB) , ... August 27, 2020 ... ... Loren DePinto, has joined the Walk-in Dermatology team in its Greenvale, New York ... Long Island Nail and Skin Care Institute. She is certified in chemical peels, ...
Breaking Medicine News(10 mins):
(Date:9/1/2020)... ... September 01, 2020 , ... Mara C. Weinstein ... Surgery at the University of Rochester Medical Center, in Upstate New York. She ... Boston, with clinical faculty from the Harvard and Yale Departments of Dermatology and ...
(Date:9/1/2020)... ... September 01, 2020 , ... September is National Ovarian ... for more deaths than any other cancer of the female reproductive system. The ... ovarian cancer and about 14,000 women will die from this disease. Throughout the ...
(Date:8/31/2020)... ... 31, 2020 , ... Cloudticity announced today that Network Products ... winner in the 15th Annual 2020 Network PG’s IT World Awards®. , The ... Network Products Guide honoring achievements of world’s best in organizational performance, product and ...
Breaking Medicine Technology:
Cached News: